TheraRadar

Pharma Intelligence, Simplified

← Back
Data updated: Mar 10, 2026

ACME LABS

Pharmaceuticals
Generics

ACME LABS is a generic drug manufacturer with 3 FDA-approved products.

2007
Since
3
Drugs
-
Trials
11
Approved (2yr)

Key Drugs

No active drugs

Recent Activity

CLOPIDOGREL BISULFATE 2025-09-11
Labeling
CLOPIDOGREL BISULFATE 2025-08-01
Labeling
CLOPIDOGREL BISULFATE 2025-08-01
Labeling
CLOPIDOGREL BISULFATE 2025-02-25
Labeling
CLOPIDOGREL BISULFATE 2025-02-25
Labeling
CLOPIDOGREL BISULFATE 2025-02-11
Labeling
ZOLPIDEM TARTRATE 2025-01-14
Labeling
ZOLPIDEM TARTRATE 2024-12-06
Labeling
CLOPIDOGREL BISULFATE 2024-09-20
CLOPIDOGREL BISULFATE 2024-07-22
Labeling
SEC Filings Pro
Loading...

Therapeutic Focus

Score weights: Approved drugs ×3, Phase 3 ×2, Phase 2 ×1, Phase 1 ×0.5

No indication data

Pipeline Strength Pro

Loading...